Aztreonam is a monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used as an active pharmaceutical ingredient for infections involving gram-negative bacteria, particularly of the meninges, bladder, and kidneys.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 78110-38-0
Tesevatinib
pharmaceutical raw material
Diclofenac diethylamine
pharmaceutical raw material
Paroxetine hydrochloride
pharmaceutical raw material
Rosiptor
pharmaceutical raw material
2-[(Z)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-2-methylpropanoic acid
WZPBZJONDBGPKJ-VEHQQRBSSA-N
C[C@H]1[C@@H](C(=O)N1S(=O)(=O)O)NC(=O)/C(=N\OC(C)(C)C(=O)O)/C2=CSC(=N2)N